We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · February 17, 2021

Effect of Disease-Modifying Therapy on Disability in Relapsing–Remitting MS Over 15 Years



Additional Info

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
Neurology 2021 Feb 02;96(5)e783-e797, T Kalincik, I Diouf, S Sharmin, C Malpas, T Spelman, D Horakova, EK Havrdova, M Trojano, G Izquierdo, A Lugaresi, A Prat, M Girard, P Duquette, P Grammond, V Jokubaitis, A van der Walt, F Grand'Maison, P Sola, D Ferraro, V Shaygannejad, R Alroughani, R Hupperts, M Terzi, C Boz, J Lechner-Scott, E Pucci, V Van Pesch, F Granella, R Bergamaschi, D Spitaleri, M Slee, S Vucic, R Ampapa, P McCombe, C Ramo-Tello, J Prevost, J Olascoaga, E Cristiano, M Barnett, ML Saladino, JL Sanchez-Menoyo, S Hodgkinson, C Rozsa, S Hughes, F Moore, C Shaw, E Butler, O Skibina, O Gray, A Kermode, T Csepany, B Singhal, N Shuey, I Piroska, B Taylor, M Simo, CA Sirbu, A Sas, H Butzkueven

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading